Are Rhodiola rosea and Schisandra chinensis safe and effective for treating mild-to-moderate anxiety in otherwise healthy adults?

Rhodiola and Schisandra Are Not Recommended as Primary Treatment for Anxiety

Neither Rhodiola rosea nor Schisandra chinensis should be used as primary treatment for mild-to-moderate anxiety in otherwise healthy adults, as they lack guideline support and robust clinical evidence for anxiety disorders. The established first-line treatments for anxiety remain cognitive-behavioral therapy (CBT), behavioral activation, structured physical activity, and evidence-based psychosocial interventions 1.

Why These Supplements Are Not Recommended

Absence from Clinical Guidelines

The most recent and authoritative anxiety treatment guidelines (ASCO 2023, AACAP 2020) make no mention of herbal supplements including Rhodiola or Schisandra as treatment options 1, 2. These guidelines consistently recommend:

• First-line: CBT, behavioral activation, structured exercise, and psychosocial interventions with empirically supported components 1
• Second-line (when first-line fails or unavailable): Pharmacotherapy with SSRIs or other anxiolytics 1

Limited and Low-Quality Evidence

Rhodiola rosea:

• Only one small pilot study (n=10) showed HARS score reduction in GAD, but this was an uncontrolled open-label trial 3
• A non-placebo controlled trial (n=80) showed anxiety reduction, but the authors themselves acknowledge inability to determine causality 4
• Most recent preclinical data (2026) shows promise in mice but lacks human validation 5

Schisandra chinensis:

• One recent RCT (2026) combined Schisandra with Rhodiola and holy basil, showing stress reduction, but cannot isolate Schisandra's individual effect 6
• FDA labeling lists Schisandra only as an inactive ingredient in topical acne products 7
• A perioperative guideline recommends holding Schisandra 2 weeks before surgery due to potential immunosuppressive interactions 8

Evidence-Based Treatment Algorithm for Anxiety

Step 1: Severity Assessment

Use validated screening tools (HARS, HADS, GAD-7) to determine symptom severity 2

Step 2: First-Line Treatment (Moderate Anxiety)

Offer one of the following 1:

• Individual or group CBT
• Behavioral activation therapy
• Structured physical activity/exercise program
• Psychosocial interventions with relaxation and problem-solving components

Step 3: Pharmacotherapy (If First-Line Fails or Unavailable)

Consider SSRIs or other anxiolytics when 1:

• Patient lacks access to psychological interventions
• Patient expresses preference for medication
• No improvement after adequate trial of first-line treatment
• Severe symptoms or functional impairment present

Step 4: Combination Treatment

For more severe presentations, combination therapy (CBT + SSRI) may be superior to monotherapy 9

Critical Safety Considerations

If considering herbal supplements despite lack of guideline support:

• Schisandra: Must be discontinued 2 weeks before any surgical procedure 8
• Drug interactions: Both supplements may interact with medications metabolized by cytochrome P450 enzymes
• Lack of standardization: Herbal preparations vary widely in active constituent concentrations
• Delayed definitive treatment: Using unproven supplements may postpone evidence-based interventions

Common Pitfalls to Avoid

1. Mistaking traditional use for clinical efficacy - Historical use does not equal proven effectiveness for anxiety disorders
2. Relying on preclinical data - Animal studies and in vitro mechanisms do not translate reliably to human anxiety treatment 10, 11
3. Accepting non-placebo controlled trials - Without proper controls, observed effects may represent natural symptom fluctuation or placebo response 4
4. Ignoring opportunity cost - Time spent on unproven treatments delays access to interventions with strong evidence 1

The Bottom Line

While emerging research suggests potential stress-modulating properties of these adaptogens, the current evidence base is insufficient to recommend them for treating anxiety disorders. The 2023 ASCO guidelines provide clear, evidence-based pathways that prioritize psychological interventions and, when necessary, pharmacotherapy with established safety profiles 1. Patients seeking anxiety treatment should be directed toward these proven modalities rather than herbal supplements lacking guideline endorsement and robust clinical validation.